Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.4%

27 terminated/withdrawn out of 236 trials

Success Rate

79.2%

-7.3% vs industry average

Late-Stage Pipeline

10%

23 trials in Phase 3/4

Results Transparency

2%

2 of 103 completed trials have results

Key Signals

43 recruiting2 with results22 terminated5 withdrawn

Enrollment Performance

Analytics

N/A
82(43.9%)
Phase 2
57(30.5%)
Phase 1
25(13.4%)
Phase 3
22(11.8%)
Phase 4
1(0.5%)
187Total
N/A(82)
Phase 2(57)
Phase 1(25)
Phase 3(22)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (236)

Showing 20 of 236 trials
NCT00333099Phase 4Completed

INEC Study: Immuno-modulating Enteral Nutrition in Cancer

Role: collaborator

NCT02029001Phase 2Recruiting

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Role: lead

NCT06408402Recruiting

Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers

Role: collaborator

NCT04116541Phase 2Recruiting

A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.

Role: lead

NCT01813136Phase 2Completed

Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma

Role: lead

NCT07679841Phase 1Not Yet Recruiting

Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients

Role: lead

NCT06346197Phase 3Recruiting

Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas

Role: lead

NCT05180695Phase 1Active Not Recruiting

HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas

Role: lead

NCT05947136Not ApplicableRecruiting

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

Role: lead

NCT07632560Not ApplicableRecruiting

CANUT Junior : Assessment of Sensory Abilities and Eating Behavior in Pediatric Oncology: a Feasibility Study

Role: lead

NCT05151718Recruiting

Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

Role: collaborator

NCT07622420Not Yet Recruiting

ProspectiveFemaleAYA - Late Effects of Cancer Therapies on Gonadal Function, Fertility, Efficiency of Fertility Preservation Procedures and Pregnancy Outcomes

Role: collaborator

NCT07243470Phase 1Recruiting

Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors

Role: lead

NCT07579507Not ApplicableNot Yet Recruiting

Heterogeneity of Oral Carcinogenesis: From PrEneoplasia to Invasive Squamous Cell Carcinoma

Role: lead

NCT07243483Not ApplicableRecruiting

Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic Leukemia

Role: lead

NCT06827366Not ApplicableRecruiting

Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)

Role: lead

NCT04354233Not ApplicableCompleted

A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer

Role: lead

NCT07499921Not ApplicableNot Yet Recruiting

Clinical and BIOgical Analyses of RECtal Tumors

Role: lead

NCT07555600Not ApplicableNot Yet Recruiting

Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors

Role: lead

NCT06385691Phase 2Recruiting

Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.

Role: lead